Cargando…

517. Safety and Tolerability of Intramuscular (IM) Sotrovimab 500 mg Administered at Different Injection Sites: Results from the Phase I COSMIC Study

BACKGROUND: Sotrovimab is a dual-action Fc-engineered human monoclonal antibody (mAb), developed for early treatment of mild-to-moderate COVID-19. We evaluated the safety and tolerability of sotrovimab 500 mg administered intramuscularly (IM) at dorsogluteal (DG), anterolateral (AL) thigh and deltoi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, Jennifer, Chen, Wen-Hung, Daniluk, Jerzy, Parra, Sergio, Turner, Megan, Sanchez-Pearson, Yasmin, Sakar, Prosenjit, Hawes, Ian A, Aylott, Alicia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678011/ http://dx.doi.org/10.1093/ofid/ofad500.586

Ejemplares similares

1154. Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19
por: Gupta, Anil K, et al.
Publicado: (2022)

Memorandum 517
por: Peyaud, B
Publicado: (1993)

Sotrovimab for COVID-19
Publicado: (2021)

Sotrovimab: First Approval
por: Heo, Young-A
Publicado: (2022)

1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab
por: Agostini, Maria L, et al.
Publicado: (2022)

Sedative effects of intramuscular alfaxalone administered to cats
por: TAMURA, Jun, et al.
Publicado: (2015)

Placental Expression of miR-517a/b and miR-517c Contributes to Trophoblast Dysfunction and Preeclampsia
por: Anton, Lauren, et al.
Publicado: (2015)

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial
por: Shapiro, Adrienne E, et al.
Publicado: (2023)

Effect of Ion Corrosion on 517 Phase Stability
por: Wang, Guijia, et al.
Publicado: (2020)

FRI517 BIUX(2)X(2)
por: Dash, Kalpana, et al.
Publicado: (2023)

Brand versus generic dispensing trend for ciprofloxacin 500 mg, levofloxacin 500 mg, and moxifloxacin 400 mg (oral dosage forms) among pharmacies of Karachi, Pakistan
por: Zehra, Fatima, et al.
Publicado: (2017)

Sotrovimab: Emergence of acquired resistance: 4 case reports
Publicado: (2022)

Pharmacokinetic Studies in Elasmobranchs: Meloxicam Administered at 0.5 mg/kg Using Intravenous, Intramuscular, and Oral Routes to Nursehound Sharks (Scyliorhinus stellaris)
por: Morón-Elorza, Pablo, et al.
Publicado: (2022)

Final Overall Survival: Fulvestrant 500mg vs 250mg in the Randomized CONFIRM Trial
por: Leo, Angelo Di, et al.
Publicado: (2013)

Genome Sequence of the Yeast Saprochaete ingens CBS 517.90
por: Hodorová, Viktória, et al.
Publicado: (2019)

SAT-517 A Rare Case of Lithium-Induced Thyroiditis
por: Lokshin, Vladimir, et al.
Publicado: (2020)

517 Understanding Distinctions in the Implementation of Learning Health System (LHS)
por: Easterling, Doug, et al.
Publicado: (2022)

SAT517 Papillary Thyroid Cancer in Thyroglossal Duct Cyst.
por: Castellanos, Paula Lorena, et al.
Publicado: (2023)

Erratum: Pharmacokinetic studies in elasmobranchs: Meloxicam administered at 0.5 mg/kg using intravenous, intramuscular, and oral routes to nursehound sharks (Scyliorhinus stellaris)
Publicado: (2023)

Influence of endotoxin induced fever on the pharmacokinetics of intramuscularly administered cefepime in rabbits
por: Goudah, Ayman, et al.
Publicado: (2006)

Plasma pharmacokinetic profile and efficacy of meloxicam administered subcutaneously and intramuscularly to sheep
por: Woodland, Alyssa N., et al.
Publicado: (2019)

Faecal concentrations of ceftiofur metabolites in finisher pigs administered intramuscularly with ceftiofur
por: Gaire, Tara N., et al.
Publicado: (2021)

497. Safety and tolerability of 2000mg intravenous sotrovimab dose in immunocompromised participants uninfected with SARS-CoV-2 in the PROTECT-V trial
por: Dosanjh, Davinder, et al.
Publicado: (2023)

Use of Sotrovimab in a Pregnant Patient With COVID-19 Infection
por: Gupta, Isha, et al.
Publicado: (2022)

Effectiveness of Sotrovimab in the Omicron Storm Time: A Case Series
por: Cicchitto, Gaetano, et al.
Publicado: (2022)

Efficacy and Safety of Terbinafine 500 mg Once Daily in Patients with Dermatophytosis
por: Babu, P Ravindra, et al.
Publicado: (2017)

512. Interim Results of a Prospective Cohort Study to Monitor the Emergence of Resistance in Immunocompromised Non-Hospitalized Patients With COVID-19 Who Were Treated with Sotrovimab in Great Britain: LUNAR Study 
por: Breuer, Judith, et al.
Publicado: (2023)

MON-517 Treatment of Gorham-Stout Disease with Combination Sirolimus and Denosumab
por: Hartley, Iris, et al.
Publicado: (2019)

SUN-517 Methimazole-Induced Neutropenia in Premature Twins with Graves’ Disease
por: Ballestas, Estefania Rodriguez, et al.
Publicado: (2020)

Pharmacokinetics and pharmacodynamics of intranasal and intramuscular administration of naloxone in working dogs administered fentanyl
por: Barr, Ciara A., et al.
Publicado: (2023)

Draft Genome Sequence of the Plant Growth-Promoting Bacterium Bacillus subtilis Strain BZR 517, Isolated from Winter Wheat, Now Reclassified as Bacillus velezensis Strain BZR 517
por: Radchenko, Vitaly V., et al.
Publicado: (2020)

Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL
por: Casado, JL, et al.
Publicado: (2010)

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial
por: Cooper, David A., et al.
Publicado: (2016)

A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovarian stimulation in an ART programme (IVF)
por: Alviggi, Carlo, et al.
Publicado: (2007)

Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects
por: Scoble, Patrick J., et al.
Publicado: (2015)

A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer
por: Robertson, John FR, et al.
Publicado: (2013)

Quality assessment of nine paracetamol 500 mg tablet brands marketed in Saudi Arabia
por: AlSwayeh, Reem, et al.
Publicado: (2021)

Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022)

Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis
por: Ao, Guangyu, et al.
Publicado: (2022)

Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection
por: Weber, Sven C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gmfj0gc80qoa0k81stl1eg3rf6